• Join
  • Login
  • Contact

Search abstracts

Improving consumer access to medicines: innovative medicines reclassification in New Zealand (NZ)

  • At: 2012 FIP Congress in Amsterdam (the Netherlands)
  • Type: Presentations + Posters
  • By: GAULD, Natalie (University of Auckland, General Practice and Primary Healthcare, Auckland, New Zealand)
  • Co-author(s): Kelly, F.J. (University of Auckland, Auckland, New Zealand)
    Emmerton, L. (Curtin University, Perth, Australia)
    Buetow, S. (University of Auckland, Auckland, New Zealand)
  • Abstract:

    Background: Prescription to non-prescription reclassification has slowed in many developed countries. However, despite a small population and negative pharmaceutical industry environment, reclassification is progressing in NZ, with first-in-world reclassifications of oseltamivir, famciclovir and calcipotriol.Objective: To ascertain why NZ is one


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses